Ask the Experts: Hematology-Oncology
Medscape's Ask the Experts allows you to ask members of a panel of leading experts for advice or information. You also have the opportunity to share your own views and insights by clicking the "Discuss this" link at the top of each response.
Ask the Experts
- Do Blood Transfusions Affect the INR?
- How Should I Manage Patients With Sickle Cell Anemia and Hepatitis C?
- What Risk Factors Are Associated With Antithyroid Drug-Induced Agranulocytosis?
- Can Opioid Tolerance Be Treated by Increasing the Opioid Dose?
- Endoscopic Eradication Therapy for Barrett's Esophagus
- What Antibiotic Covers Methicillin-sensitive Staphylococcus aureus (MSSA) Infection?
- Does Calcitonin Help Relieve Neuropathic Pain?
- When Is Skin Testing for Penicillin Allergy Indicated?
- Does Vitamin B12 Help Relieve Fatigue?
- Is It Safe To Order Drugs From Overseas Pharmacies?
- What Do Pathologic Skin Lesions in Elderly Patients Look Like?
- How Should the APN Code for a Counseling Visit?
- Can Opiates Be Administered by Nebulizer?
- What Is the Maximum Safe Dose of Opioids?
- Do Antihistamines Relieve Drug-Induced Bone Pain?
- Can Fentanyl Patches Be Replaced Sooner to Improve Pain Control?
- Treating Hot Flashes Induced by Tamoxifen
- Treatment for an Endoscopically Resected Polyp When the Histologic Findings Show Adenocarcinoma?
- Can Ondansetron Be Administered Transdermally?
- What Are the Latest Recommendations for Ovarian Cancer Screening?
Disclaimer
The information in this web site reflects the views of the authors only and not Medscape. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers should verify all information and data before treating patients or utilizing any therapies noted in this program.
Expert Panel
Harold J. Burstein, MD, PhD, Assistant Professor, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.
Avraham Eisbruch, MD, Professor of Radiation Oncology, University of Michigan, and Clinical Division Director, University of Michigan Hospital, Ann Arbor, MI.
John D. Hainsworth, MD, Director, Clinical Research, Sarah Cannon Cancer Center, Nashville, Tennessee.
Manuel Hidalgo, MD, Associate Professor, Director, Johns Hopkins University, Baltimore, Maryland.
Clifford Hudis, MD, Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Associate Professor of Medicine, Joan and Sanford I. Weill Medical College, Cornell University, New York, NY.
Corey J. Langer, MD, Associate Professor of Medicine, Temple University, Philadelphia, Pennsylvania; Medical Director, Thoracic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
John S. Macdonald, MD, Professor of Medicine, New York Medical College, Valhalla, New York; Chief, Gastrointestinal Oncology Service, St. Vincent's Catholic Medical Center-Manhattan, New York, NY.
Marshall Posner, MD, Associate Professor of Medicine, Adult Oncology; Medical Director, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Kathleen I. Pritchard, MD, FRCPC, Head, Clinical Trials and Epidemiology, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada; Clinical Director, Ontario Clinical Oncology Group, Toronto, Ontario, Canada.
Joseph A. Sparano, MD, Professor of Medicine, Albert Einstein College of Medicine, Bronx, New York; Director, Breast Evaluation Center, Montefiore-Einstein Cancer Center, Bronx, New York.
Paul A. Vasey MSc, MD, MRCP, Senior Lecturer in Medical Oncology and Honorary Consultant Cancer Physician, Cancer Research Campaign Department of Medical Oncology, University of Glasgow and Beatson Oncology Centre, Glasgow, Scotland, UK.